Analyst Ratings for Pharmacyclics (PCYC) [Neutrals]
PCYC Rating Summary
PCYC Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$69.77 (-17.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
80.00 (N/A) |
76.54 | 84.89 | 10.91% | Details |
| 3/20/2013 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
86.62 | 84.89 | -2% | Details |
| 2/19/2013 | Leerink Swann | Downgrade | Market Perform (Outperform) |
97.00 (80.00) |
87.00 | 84.89 | -2.43% | Details |
| 1/14/2013 | Lazard Capital | Downgrade | Neutral (Buy) |
N/A (N/A) |
67.42 | 84.89 | 25.91% | Details |
| 8/24/2012 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
64.91 | 84.89 | 30.78% | Details |
| 8/20/2012 | Roth Capital | Downgrade | Neutral (Buy) |
57.00 (57.00) |
62.89 | 84.89 | 34.98% | Details |
| 8/2/2012 | Needham & Company | Downgrade | Hold (Buy) |
N/A (N/A) |
53.44 | 84.89 | 58.85% | Details |
| 7/13/2012 | Bernstein | New Coverage | Market Perform (N/A) |
51.00 (N/A) |
54.51 | 84.89 | 55.73% | Details |
| 12/9/2011 | Global Hunter Securities | Downgrade | Neutral (N/A) |
15.00 (N/A) |
13.35 | 84.89 | 535.88% | Details |
